Company Filing History:
Years Active: 2001-2003
Title: Esther Eytan: Innovator in Ubiquitin Carrier Polypeptides
Introduction
Esther Eytan is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of biotechnology, particularly in the area of ubiquitin carrier polypeptides. With a total of 2 patents, her work has implications for understanding cell cycle regulation and potential therapeutic applications.
Latest Patents
Eytan's latest patents focus on cyclin-selective ubiquitin carrier polypeptides. These patents disclose novel human and clam ubiquitin carrier polypeptides that are involved in the ubiquitination of cyclins A and/or B. Additionally, the patents describe inhibitors of such polypeptides, nucleic acids encoding these polypeptides and inhibitors, antibodies specific for these polypeptides, and methods of their use.
Career Highlights
Throughout her career, Esther Eytan has worked with esteemed institutions, including Harvard College. Her research has contributed to advancements in the understanding of protein regulation and cellular processes.
Collaborations
Eytan has collaborated with notable scientists such as Joan V. Ruderman and Avram Hershko, further enhancing the impact of her research in the scientific community.
Conclusion
Esther Eytan's innovative work in the field of ubiquitin carrier polypeptides showcases her dedication to advancing biotechnology. Her contributions continue to influence research and potential applications in medicine.